Key terms
About PRPO
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PRPO news
Apr 01
4:45pm ET
Precipio to hold a conference call
Apr 01
12:45pm ET
Precipio to hold a conference call
Mar 26
4:53pm ET
Precipio Inc Schedules Year-End Shareholder Update Call
Feb 06
10:05am ET
Precipio trading resumes
Feb 06
10:01am ET
Precipio, Cardinal Health enter distribution agreement for HemeScreen portfolio
Feb 06
10:00am ET
Precipio trading halted, volatility trading pause
Jan 23
10:04am ET
Precipio reports Q4 cash burn from operations below $100,000
Jan 17
10:40am ET
Precipio trading resumes
Jan 17
10:31am ET
Precipio enters distribution agreement for IV-Cell, HemeScreen in Japan
Jan 17
10:30am ET
Precipio trading halted, volatility trading pause
No recent press releases are available for PRPO
PRPO Financials
Key terms
Ad Feedback
PRPO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PRPO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
